Haleon earnings were $1.9B for the trailing 12 months ending Dec 31, 2024, with 36.7% growth year over year. The latest HLN earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HLN reported annual earnings of $1.8B, with 35.7% growth.
HLN past earnings growth
How has HLN's earnings growth performed historically?
Haleon (NYSE: HLN) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total HLN earnings for the quarter were N/A. In the same quarter last year, Haleon's earnings per share (EPS) was N/A.
As of the last Haleon earnings report, Haleon is currently profitable. Haleon's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $1.80 billion, a 35.75% increase year over year.
What was HLN's earnings growth in the past year?
As of Haleon's earnings date in Q2 2025, Haleon's earnings has grown 36.68% year over year. This is 18.39 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 55.07%. HLN earnings in the past year totalled $1.87 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.